# Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

> **NCT02469077** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 117 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **BEHAVIORAL:** 6 week aerobic exercise intervention
- **DRUG:** Placebo
- **DRUG:** Morphine
- **DRUG:** naloxone

## Key facts

- **NCT ID:** NCT02469077
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2020-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469077, "Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02469077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*